MedPath

The effect of experimental hyperglycemia and AT1 receptor blockade on renal hemodynamics in impaired glucose tolerance

Completed
Conditions
Impaired glucose tolerance/ renal changes in prediabetes
Nutritional, Metabolic, Endocrine
Registration Number
ISRCTN07427212
Lead Sponsor
Technical University of Munich (Germany)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
24
Inclusion Criteria

1. Males
2. 18-70 years old
3. Impaired Glucose Tolerance (for the intervention group [IGT-Group]) (tested by the oral glucose tolerance test according to the World Health Organisation) and normoglycemic patients (for control group [healthy subjects])

Exclusion Criteria

1. Renal or liver insufficiency
2. Micro-or macro-albuminuria
3. Overt diabetes mellitus

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The following were measured at rest (U1 rest, U2 rest) and during hyperglycemic stress testing (U1 stress, U2 stress) with and without AT1 receptor blocker treatment:<br>1. Glomerular filtration rate (inulin clearance) <br>2. Renal plasma flow (Para-AminoHippurate [PAH] clearance) <br><br>U1: Without AT1 receptor blocker<br>U2: After a 4-week treatment with valsartan
Secondary Outcome Measures
NameTimeMethod
The following were assessed at U1 and U2: <br>1. High-sensitivity C-Reactive Protein (CRP) <br>2. Adiponectin <br>3. HbA1c (blood tests) <br><br>U1: Without AT1 receptor blocker <br>U2: After a 4-week treatment with valsartan
© Copyright 2025. All Rights Reserved by MedPath